Subscribe to Newsletter

Search

Reset Filter

4106 search results for ‘*’

Discovery & Development Drug Delivery

Mini Magnetic Medics

| Rob Coker

Nanorobots developed by engineers from the UK and China have delivered precision treatment to brain aneurysms

Business & Regulation Trends & Forecasts

The Building Blocks of Engagement

| Aaron Bean | 3 min read

Shifting trends demand a change in how pharma field reps interact with healthcare professionals

Manufacture Technology and Equipment

Built for You

| Sponsored by Asahi Kasei Bioprocess | 6 min read

How Asahi Kasei Bioprocess is incorporating ergonomics into biopharma equipment to make manufacturing safer, more efficient, and more productive.

Business & Regulation Digital Technologies

The Changing Landscape of Decentralized Clinical Trials

| Diane Leclerc | 2 min read

How technology is enabling new access to clinical trials for those without the means to participate in traditional methods

Manufacture Quality & Compliance

Facing Up to the New Nemesis of Pharma: Nitrosamines

| 8 min read

What’s going on with nitrosamines? Naiffer Romero from the USP walks us through frequently asked questions.

Discovery & Development Drug Delivery

Polio Vaccine Rollout in Gaza Commences

| Rob Coker | 2 min read

A campaign to vaccinate children against polio in Gaza has begun, but success will depend on the vital role of the pharmaceutical industry.

Discovery & Development Drug Discovery

Boosting Naloxone’s Effectiveness Against Opioid Overdoses

| Jamie Irvine

A recent US-based study discovered a new compound that could enhance naloxone’s ability to fend off more potent opioids.

Single ingredient optimization supports the expansion of pluripotent stem cells

| Contributed by Novo Nordisk

This study highlights the benefits of incorporating Recombinant Insulin in hiPSC culture to enhance the quality and productivity of these cells

Manufacture Technology and Equipment

The Nonprofit Model for Manufacturing

| Stephanie Vine | 13 min read

Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working. We get the story behind their facility in Petersburg.

Business & Regulation Standards & Regulation

The Demands and Ethical Obligations of the DSCSA

| Matt Sample, Gregg Gorniak | 3 min read

The deadline for the US Drug Supply Chain Security Act is approaching.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register